SCHEMBL15533854

SCHEMBL15533854

CCCCOC(=O)C[C@@H](C)c1ccc(Cl)c(N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ HPGD P15428 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PHGDH O43175 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15534311 1.00 ALDH1A1 (0.44) ALDH1A1L3MBTL1TDP1HPGDSMN1; SMN2
SCHEMBL23509591 0.83 L3MBTL1 (0.40) ALDH1A1L3MBTL1TDP1HPGDSMN1; SMN2
SCHEMBL22491782 0.83 L3MBTL1 (0.39) ALDH1A1L3MBTL1TDP1HPGDSMN1; SMN2
SCHEMBL25600200 0.81 ALDH1A1 (0.43) ALDH1A1L3MBTL1TDP1SMN1; SMN2LMNA
SCHEMBL1932493 0.79 KDM4E (0.40) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL1932163 0.79 KDM4E (0.40) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL1932001 0.79 KDM4E (0.40) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL5720935 0.78 L3MBTL1 (0.45) ALDH1A1L3MBTL1TDP1HPGDSMN1; SMN2
SCHEMBL15709827 0.78 FFAR1 (0.50) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL15709624 0.78 FFAR1 (0.50) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852573-A1 N-[3-(2-CARBOXYETHYL)PHENYL]PIPERIDIN-1-YLACETAMIDE DERIVATIVES AND USE THEREOF AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2015-04-01 — — EP disclosed
WO-2013174736-A1 N-[3-(2-CARBOXYETHYL)PHENYL]PIPERIDIN-1-YLACETAMIDE DERIVATIVES AND USE THEREOF AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-11-28 — — WO disclosed
Send feedback